Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Canagliflozin may reduce albuminuria, eGFR decline in patients with type 2 diabetes
Canagliflozin may reduce albuminuria and patient-specific eGFR decline in patients with type 2 diabetes and microalbuminuria, researchers found in a parallel, open-labeled trial.
QWINT: Once-weekly basal insulin noninferior to daily insulins in type 2 diabetes
A novel once-weekly basal insulin conferred noninferior HbA1c reductions compared with daily insulins for insulin-naive adults with type 2 diabetes and those who switched from daily injections, according to topline results from two trials.
Log in or Sign up for Free to view tailored content for your specialty!
‘Reassuring’ findings suggest GLP-1 receptor agonists do not increase suicide risk
Results from two studies found no association between the use of GLP-1 receptor agonists and increased risk for suicide, suicidal thoughts or depression, findings published in JAMA Internal Medicine showed.
Peter Libby, MD, to keynote annual CMHC, with focus on revolutionizing atherosclerosis care
The Cardiometabolic Health Congress announced that Peter Libby, MD, one of the foremost authorities in atherosclerosis, will deliver the keynote address at its upcoming 19th annual conference.
Digital access key to boosting diabetes self-management education uptake for older adults
More than one-third of older adults with diabetes lack the digital tools necessary for virtual diabetes self-management education, and providers can play a role in promoting digital inclusion, according to a speaker.
Semaglutide cuts risk for worsening heart failure, CV death among adults with HFpEF
Semaglutide cut the risk for worsening heart failure and CV death for adults with HF with preserved ejection fraction, according to data presented at the European Society of Cardiology Congress and simultaneously published in The Lancet.
Providers should assess HbA1c and CGM metrics in diabetes management
Both HbA1c and continuous glucose monitoring metrics have limitations, and providers should not rely on a single metric for managing a patient’s diabetes, according to two speakers.
CGM use in early pregnancy offers ‘window of opportunity’ to improve perinatal outcomes
Women with fetal overgrowth or hypertensive disorders of pregnancy have notable continuous glucose monitor-derived glycemic patterns detected during early pregnancy, sometimes without a gestational diabetes diagnosis, researchers reported.
Finerenone improves outcomes in patients with mildly reduced, preserved ejection fraction
In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.
Choice to halt RAS therapy before major surgery can be left to patient, physician
Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read